Epilepsy Research

Epilepsy is a group of neurological conditions consisting of recurrent, usually unprovoked epileptic seizures. Epileptic seizures have recently been defined as "a transient occurrence of signs and/or symptoms due to abnormal, excessive or synchronous neuronal activity in the brain". Epilepsy is one of the most common disorders of the brain, with one in 10 people suffering at least one seizure in their lifetime. There are over 40 different types of epilepsy, each of which presents with its own unique combination of seizure type, typical age of onset, EEG findings, treatment, and prognosis.

Epilepsy Research Products Targets

Products for Epilepsy Research - Page 28

  1. Cat.No. Product Name Information/Activity
  2. BCC7753 DL-AP5 Sodium salt 1303993-72-7 DL-AP5 Sodium salt chemical structure
  3. BCC6553 D-AP5 D-AP5 is a NMDA receptor antagonist. D-AP5 chemical structure
  4. BCC6552 DL-AP5 76326-31-3 DL-AP5 chemical structure
  5. BCC6554 L-AP5 79055-67-7 L-AP5 chemical structure
  6. BCC6551 DL-AP7 78966-69-5 DL-AP7 chemical structure
  7. BCC6631 Arcaine sulfate 14923-17-2 Arcaine sulfate chemical structure
  8. BCC6602 (R)-4-Carboxyphenylglycine 134052-68-9 (R)-4-Carboxyphenylglycine chemical structure
  9. BCC7078 CGP 37849 CGP 37849 is a potent, competitive and orally active N-methyl-D-aspartate (NMDA) receptor antagonist. CGP 37849 is an anticonvulsant in rodents and has antidepressant and anxiolytic-like effects. CGP 37849 chemical structure
  10. BCC7053 CGP 39551 127910-32-1 CGP 39551 chemical structure
  11. BCC7087 CGP 78608 hydrochloride CGP 78608 hydrochloride is a highly potent and selective antagonist at the glycine-binding site of the NMDA receptor, with an IC50 of 6 nM. CGP 78608 acts as a potentiator of GluN1/GluN3A-mediated glycine currents, with an estimated EC50 in the low nM range (26.3 nM). Anticonvulsant activity. CGP 78608 hydrochloride chemical structure

Items 271 to 280 of 560 total